{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Midazolam&page=2", "query": { "intervention": "Placebo Midazolam", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Midazolam&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-28T09:08:14.167Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01158820", "title": "Alternative Sedation During Bronchoscopy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Sedation" ], "interventions": [ { "name": "Dexmedetomidine load", "type": "DRUG" }, { "name": "Ketamine load", "type": "DRUG" }, { "name": "Midazolam load", "type": "DRUG" }, { "name": "Fentanyl load", "type": "DRUG" }, { "name": "Dexmedetomidine maintenance", "type": "DRUG" }, { "name": "Ketamine maintenance", "type": "DRUG" }, { "name": "Midazolam demand", "type": "DRUG" }, { "name": "Fentanyl demand", "type": "DRUG" }, { "name": "Benadryl demand", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 50, "start_date": "2010-06", "completion_date": "2012-05", "has_results": true, "last_update_posted_date": "2019-02-26", "last_synced_at": "2026-09-28T09:08:14.167Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01158820" }, { "nct_id": "NCT01757756", "title": "Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Glucose Metabolism Disorders" ], "interventions": [ { "name": "Pf-05175157", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 12, "start_date": "2012-10", "completion_date": "2012-11", "has_results": false, "last_update_posted_date": "2012-12-31", "last_synced_at": "2026-09-28T09:08:14.167Z", "location_count": 1, "location_summary": "South Miami, Florida", "locations": [ { "city": "South Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01757756" }, { "nct_id": "NCT03140527", "title": "Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer", "Cystic Fibrosis" ], "interventions": [ { "name": "PTI-801", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "PTI-808", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Proteostasis Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 171, "start_date": "2017-04-10", "completion_date": "2020-02-27", "has_results": false, "last_update_posted_date": "2020-04-30", "last_synced_at": "2026-09-28T09:08:14.167Z", "location_count": 33, "location_summary": "Birmingham, Alabama • Anchorage, Alaska • Stanford, California + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Stanford", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Altamonte Springs", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03140527" }, { "nct_id": "NCT02620501", "title": "Does Use of Topical Lidocaine in EGD Reduce Amount of IV Midazolam and Fentanyl Required and Shorten Recovery Time", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dysphagia", "GERD", "Abdominal Pain" ], "interventions": [ { "name": "Lidocaine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brooke Army Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "18 Years to 89 Years" }, "enrollment_count": 106, "start_date": "2015-07", "completion_date": "2016-05", "has_results": false, "last_update_posted_date": "2015-12-03", "last_synced_at": "2026-09-28T09:08:14.167Z", "location_count": 1, "location_summary": "Fort Sam Houston, Texas", "locations": [ { "city": "Fort Sam Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02620501" }, { "nct_id": "NCT02522377", "title": "Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Treatment Resistant Depression", "Major Depressive Disorder", "Severe Depression" ], "interventions": [ { "name": "Ketamine", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 15, "start_date": "2015-08", "completion_date": "2018-03-01", "has_results": true, "last_update_posted_date": "2019-08-29", "last_synced_at": "2026-09-28T09:08:14.167Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02522377" }, { "nct_id": "NCT06154447", "title": "Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "VX-828", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Itraconazole", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Tezacaftor", "type": "DRUG" }, { "name": "VX-118", "type": "DRUG" }, { "name": "Deutivacaftor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vertex Pharmaceuticals Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 165, "start_date": "2023-12-12", "completion_date": "2026-07-10", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-09-28T09:08:14.167Z", "location_count": 12, "location_summary": "Hollywood, Florida • Orlando, Florida • Overland Park, Kansas + 9 more", "locations": [ { "city": "Hollywood", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06154447" }, { "nct_id": "NCT04274361", "title": "Ketamine for Pain Control After Severe Traumatic Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hospital Inpatient Trauma Injury", "Pain Management" ], "interventions": [ { "name": "Ketamine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medical College of Wisconsin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 93, "start_date": "2021-01-20", "completion_date": "2025-02-28", "has_results": false, "last_update_posted_date": "2025-03-14", "last_synced_at": "2026-09-28T09:08:14.167Z", "location_count": 1, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04274361" }, { "nct_id": "NCT03185819", "title": "Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Depressive Disorder, Major" ], "interventions": [ { "name": "Intranasal Placebo", "type": "DRUG" }, { "name": "Midazolam Placebo Solution", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Esketamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "9 Years to 17 Years" }, "enrollment_count": 147, "start_date": "2017-10-05", "completion_date": "2023-03-31", "has_results": true, "last_update_posted_date": "2025-04-29", "last_synced_at": "2026-09-28T09:08:14.167Z", "location_count": 18, "location_summary": "Hartford, Connecticut • New Haven, Connecticut • Atlanta, Georgia + 15 more", "locations": [ { "city": "Hartford", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Winfield", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03185819" }, { "nct_id": "NCT00499460", "title": "Effects of Garlic Supplements on Opioids in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Healthy, No Evidence of Disease" ], "interventions": [ { "name": "garlic powder tablets", "type": "DIETARY_SUPPLEMENT" }, { "name": "oxycodone", "type": "DRUG" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "DRUG" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "21 Years to 45 Years" }, "enrollment_count": 15, "start_date": "2006-11", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2017-04-07", "last_synced_at": "2026-09-28T09:08:14.167Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00499460" }, { "nct_id": "NCT00142493", "title": "Effect of Affective Content on Drug Induced Amnesia of Episodic Memory", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Memory Losses", "Amnesia-Memory Loss" ], "interventions": [ { "name": "Propofol", "type": "DRUG" }, { "name": "Thiopental Sodium", "type": "DRUG" }, { "name": "Dexmedetomidine Hydrochloride", "type": "DRUG" }, { "name": "Midazolam Hydrochloride", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 79, "start_date": "2004-09", "completion_date": "2008-08", "has_results": false, "last_update_posted_date": "2015-12-24", "last_synced_at": "2026-09-28T09:08:14.167Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00142493" } ] }